The cost-effectiveness of second line diabetes medication added to standard therapy in preventing type 2 diabetes related nephropathy in Germany

Authors

Institutions

Publication Details

Journal
Cost Effectiveness and Resource Allocation
Published
2026-07-27
DOI
https://doi.org/10.1186/s12962-026-00801-5
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The cost-effectiveness of second line diabetes medication added to standard therapy in preventing type 2 diabetes related nephropathy in Germany

Hanni Hille, W Schramm, Ahmed Bounekkar
Cost Effectiveness and Resource Allocation
Chronic Kidney Disease and Diabetes
article

The cost-effectiveness of second line diabetes medication added to standard therapy in preventing type 2 diabetes related nephropathy in Germany

Hanni Hille, W Schramm, Ahmed Bounekkar
article en

Abstract

No abstract available for this paper.
Cost Effectiveness and Resource AllocationVol. 24(1)
Université Claude Bernard Lyon 1 (FR), Heilbronn University (DE)
Openalex Percentile: Top 9%
Chronic Kidney Disease and Diabetes
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The cost-effectiveness of second line diabetes medication added to standard therapy in preventing type 2 diabetes related nephropathy in Germany — Hanni Hille, W Schramm, et al. · Cost Effectiveness and Resource Allocation (2026) | TGRS Research Map | TGRS